Dawn Biopharma
- Founded
- 2022
- Business Model
- B2B
About
Dawn Biopharma is an investment platform controlled by the KKR Healthcare Strategic Growth Fund II, established in 2022 to own and support a diverse portfolio of attractive biopharmaceutical companies in Europe. The platform provides flexible capital and operational expertise to biopharma companies across various therapeutic areas and development stages. Dawn Biopharma operates as an active investor and portfolio manager, participating in financing rounds alongside other leading life sciences investors including HealthCap, Gilde Healthcare, Pontifax, RA Capital Management, Novo Holdings, and SR One. The platform's managing partner, Iyona Rajkomar, is based in London.
Summary
Dawn Biopharma is a Biotech company, founded in 2022.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/dawn-biopharma"><img src="https://indexed.vc/api/badge/company/dawn-biopharma" alt="Dawn Biopharma on Indexed.vc" width="260" height="76" /></a>